Caliway Biopharmaceuticals Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat
Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world’s first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) regulatory pathway.
Liquid Biopsy Market Boom: Tools, Services, and Diagnostics Unveiled
“Liquid biopsy is a revolutionary, non-invasive method for detecting diseases like cancer through blood samples instead of traditional tissue biopsies. This market is rapidly growing, offering advanced tools, services, and diagnostics that improve early detection, monitoring, and treatment decisions worldwide.”
Executive Rehabilitation: Reclaiming Leadership Through Recovery
When high-performing executives face substance use disorders or mental health challenges, the stakes extend beyond personal well-being to encompass professional legacies, organizational responsibilities, and leadership obligations.
Neogap Therapeutics Selected for EIC Soft-landing Programme in Boston
The EIC Soft-landing Programme provides business development support and opportunities to connect with investors, academic institutions and life science stakeholders in Boston – a global hub for cancer research and biotechnology. Neogap’s combination of AI, bioinformatics and cell biology in developing personalised immunotherapy aligns well with the programme’s focus on deep tech companies.
Median Technologies Submits U.S. Application for 510(k) Clearance of eyonis® LCS
Submission based on positive data from two pivotal studies, which both met their primary endpoints. U.S. clearance expected in Q3 2025 based on average observed review timelines for radiological medical devices.
AI Analysis of Labor, Delivery Notes Finds Racial Disparities in Biased Language
Veronica Barcelona, PhD, an assistant professor at Columbia Nursing, and her colleagues also found differences in how Hispanic and Asian/Pacific Islander (API) patients were described compared to White patients.
BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies

BD SpectralFX™ Technology maximizes the number of colors that can be used in flow cytometry, allowing scientists to analyze up to 50 or more characteristics of a single cell at one time, with optimal resolution and sensitivity, which is ideal for scientists pursuing novel biomarker discovery.
CPR Therapeutics Receives Follow-on U.S. Patent for Integration of Defibrillation into an Automated CPR Device
CPR Therapeutics Inc. is an early-stage start-up supported by funding from the NSF and NIH
Piramal Pharma Ltd. Continues to Invest In USA; $90M in Expansions of Two US Sites
Addition of commercial-scale sterile injectables capabilities in Lexington, KY.
Regaining Control: Seeking Professional Help for Alcohol Addiction

Discover how seeking professional help can aid recovery from alcohol addiction and restore control over your life.
The Benefits of Luxury Residential Treatment for Addiction Recovery

When it comes to overcoming addiction, the environment in which one seeks treatment can significantly impact their recovery journey. Luxury residential treatment programs offer a unique blend of high-end amenities, personalized care, and professional support that can profoundly influence the healing process. These facilities provide more than just comfort; they create an environment conducive to […]
Innovative Strategies for Preserving Natural Teeth Health

Preserving natural teeth is essential as they play a vital role in chewing, speaking, and maintaining jaw and facial structure.